In the second half of the 20th century significant advances were made in the primary
prevention of atherosclerotic cardiovascular disease. This progress was a result of
the discovery of atherosclerotic risk factors and implementation of population-based
risk assessment and risk reduction strategies. Nonetheless, cardiovascular disease
has remained the number 1 killer in most developed countries, and it is increasingly
threatening populations in the developing world. More specifically, little progress
has been made in the identification of high-risk asymptomatic individuals who could
benefit from aggressive preventive therapies but who are unaware of the presence and
the severity of their disease. The hidden nature of the disease has made the battle
against heart attack and stroke much more difficult than the fight against other diseases.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article Info
Publication History
Published online: June 06, 2006
Identification
Copyright
© 2006 Elsevier Inc. Published by Elsevier Inc. All rights reserved.